Study identifier:4522IL/0028
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Randomized, Double-blind, Multicenter Trial to Compare the Short-term and Long-term Efficacy and Safety of ZD4522 5 and 10 mg, Simvastatin 20 mg, and Pravastatin 20 mg in the Treatment of Subjects with Hypercholesterolemia
hypercholesterolaemia
N/A
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|